Pillstats
Rx only · Suspension · Oral

Oxcarbazepine

Brands: Trileptal · Oxcarbazepine

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)32624
US makers17 labelers
Packages21
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.099$0.198$0.296$0.395Dec 2025Mar 2026Jul 2026
$0.287
Latest avg · Jul 22, 2026
-15%
Since Dec 17, 2025
17
Active US suppliers
19%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

33K67K100K134K2025 Q12025 Q22025 Q32025 Q42026 Q1
107K
Rx · 2026 Q1
51.2M
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Chartwell RX, LLCunknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Bionpharma Inc.unknown2SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
Kanchan Healthcare Incunknown1SUPPLYING
Novartis Pharmaceuticals Corporationunknown1SUPPLYING
Marlex Pharmaceuticals Incunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Epic Pharma, LLCunknown1SUPPLYING
Ascend Laboratories, LLCunknown1SUPPLYING
Precision Dose, Inc.unknown1SUPPLYING
Chartwell Governmental & Specialty RX, LLC.unknown1SUPPLYING
Biocon Pharma Incunknown1SUPPLYING
Novadoz Pharmaceuticals LLCunknown1SUPPLYING

+ 2 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.